ABEO·00289Y206·US·equity·Healthcare - Biotechnology-13D/G
ABEO (ABEONA THERAPEUTICS INC) is held by 65 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($14.3M), GEODE CAPITAL MANAGEMENT, LLC ($5.4M), GOLDMAN SACHS GROUP INC ($5.1M). Net institutional sentiment: Mixed.
See how ABEO's score breaks down across 4 SEC sources
Showing 1-20 of 68
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer